title: Penicillin concentrations in serum, milk, and urine following intramuscular and subcutaneous administration of increasing doses of procaine penicillin G in lactating dairy cows.
abstract: Eight healthy, non-pregnant, crossbred Holstein dairy cows (557-682 kg) within their first 3 months of lactation (13-21.5 kg of milk/day) were used. Cows were kept in tie stalls for the whole experiment. The 8 cows were randomly assigned to 2 (IM and SC) 4 x 4 balanced Latin square design experiments. Doses of procaine penicillin G (PPG) (300000 IU/mL) in each square were 7000, 14000, 21000 and 28000 IU/kg and were injected IM or SC once daily for 5 consecutive days. Volumes of PPG per site of injection never exceeded 20 mL. Blood was collected to determine the Cmax, Tmax, and AUC; urine and milk were also taken to measure the persistence of PPG in these fluids. Results show that serum Cmax and Tmax were only slightly affected by increasing the doses or the route of administration, whereas the AUC was linearly increased in relation to the dose injected in both modes of injection. In the urine, Cmax varied from 160 to 388 IU/mL and Tmax from 72-120 h during 5 consecutive days of PPG injection. A dose effect in Cmax was observed only for the IM route of administration and no variation (P > 0.05) was found between the IM and SC routes. Milk Cmax concentrations were only increased by the dose regimen in the IM group. At doses of 21000 and 28000 IU/kg, the IM group had a higher (P > 0.05) Cmax when compared with the SC groups. Milk PPG residues were not detectable over 96 h following the last IM injection, independently of the dose injected. However milk PPG residues were detected for up to 132 h following the last SC injection. These results show that when PPG is injected IM once daily in volumes not exceeding 20 mL/site at doses as high as 28000 IU/kg, the withdrawal period should be at least 96 h. Therefore, in the present model, there was no advantage to inject PPG by SC route to improve PPG kinetic parameters as the AUC, Cmax, or Tmax.
authors.affiliation: Faculté de médecine vétérinaire, Université de Montreal, St-Hyacinthe, Quebec. pascal.dubreuil@umontreal.ca
authors.forename: P
authors.initials: P
authors.lastname: Dubreuil
authors.forename: J
authors.initials: J
authors.lastname: Daigneault
authors.forename: Y
authors.initials: Y
authors.lastname: Couture
authors.forename: P
authors.initials: P
authors.lastname: Guay
authors.forename: D
authors.initials: D
authors.lastname: Landry
mesh_terms: D000818:Animals; D019540:Area Under Curve; D002417:Cattle / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes / Q000662:veterinary; D004350:Drug Residues / Q000032:analysis / Q000493:pharmacokinetics*; D005260:Female; D007273:Injections, Intramuscular / Q000662:veterinary; D007279:Injections, Subcutaneous / Q000662:veterinary; D007774:Lactation / Q000378:metabolism; D008892:Milk / Q000737:chemistry / Q000378:metabolism*; D010402:Penicillin G Procaine / Q000008:administration & dosage / Q000032:analysis / Q000493:pharmacokinetics*; D010406:Penicillins / Q000008:administration & dosage / Q000032:analysis / Q000493:pharmacokinetics*
chemical_list: D010406:Penicillins; D010402:Penicillin G Procaine